Datasets:
treatment_id stringlengths 17 17 | country stringclasses 7
values | year int64 2.02k 2.03k | facility stringclasses 3
values | cancer_type stringclasses 9
values | age int64 20 84 | treatment_intent stringclasses 4
values | treatment_modality stringclasses 5
values | total_fractions int64 1 39 | dose_per_fraction_gy float64 1.8 3 | total_dose_gy float64 8 70 | technique stringclasses 5
values | machine_type stringclasses 4
values | treatment_completed stringclasses 4
values | waiting_time_days int64 7 89 | simulation_done stringclasses 2
values | ct_planning_done stringclasses 2
values | image_guidance stringclasses 3
values | acute_toxicity_grade int64 0 4 | chronic_toxicity_grade int64 0 3 | response_assessed stringclasses 4
values | cost_usd float64 800 5k | scenario stringclasses 3
values |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
RT-KEN-2021-00001 | Kenya | 2,021 | Private facility | Prostate | 75 | Curative | SBRT | 39 | 2.5 | 44.9 | 2D | Linear accelerator | Yes | 40 | No | Yes | Daily | 2 | 2 | Partial | 1,628.08 | high_burden |
RT-UGA-2018-00002 | Uganda | 2,018 | Regional cancer center | Brain | 82 | Curative | SBRT | 14 | 2.7 | 33.7 | 3D-CRT | Not specified | Yes | 29 | Yes | Yes | Weekly | 1 | 3 | Partial | 2,996.87 | high_burden |
RT-KEN-2020-00003 | Kenya | 2,020 | Private facility | Lymphoma | 33 | Palliative | Combined EBRT+Brachy | 3 | 2.7 | 29.5 | 3D-CRT | Both available | No - abandoned | 37 | Yes | Yes | Weekly | 2 | 2 | Complete | 1,667.3 | high_burden |
RT-NIG-2023-00004 | Nigeria | 2,023 | Regional cancer center | Head & Neck | 44 | Adjuvant | Combined EBRT+Brachy | 25 | 2.3 | 69.9 | IMRT | Linear accelerator | Yes | 69 | Yes | Yes | null | 1 | 0 | Complete | 4,053.07 | high_burden |
RT-TAN-2023-00005 | Tanzania | 2,023 | National hospital | Brain | 55 | Adjuvant | External beam RT | 10 | 2.8 | 68 | 3D-CRT | Linear accelerator | Yes | 72 | Yes | Yes | null | 2 | 2 | Stable | 1,948.68 | high_burden |
RT-SOU-2018-00006 | South Africa | 2,018 | National hospital | Lung | 67 | Neoadjuvant | Brachytherapy | 11 | 2 | 62 | 3D-CRT | Linear accelerator | Yes | 65 | Yes | Yes | null | 3 | 0 | Partial | 4,312.55 | high_burden |
RT-SOU-2022-00007 | South Africa | 2,022 | Regional cancer center | Prostate | 32 | Curative | Palliative RT | 31 | 2.9 | 42.5 | VMAT | Linear accelerator | No - toxicity | 61 | Yes | Yes | Weekly | 1 | 0 | Stable | 3,480.99 | high_burden |
RT-TAN-2019-00008 | Tanzania | 2,019 | Private facility | Lymphoma | 45 | Curative | Palliative RT | 37 | 2 | 50.3 | IMRT | Not specified | Yes | 28 | Yes | Yes | Unknown | 1 | 0 | Partial | 1,230.03 | high_burden |
RT-TAN-2018-00009 | Tanzania | 2,018 | Private facility | Esophagus | 48 | Adjuvant | Combined EBRT+Brachy | 15 | 2.8 | 40.2 | 3D-CRT | Linear accelerator | Yes | 88 | Yes | Yes | null | 1 | 2 | Stable | 4,898.33 | high_burden |
RT-GHA-2023-00010 | Ghana | 2,023 | Regional cancer center | Cervix | 34 | Curative | Palliative RT | 15 | 2 | 45.4 | IMRT | Linear accelerator | Yes | 64 | No | No | Weekly | 1 | 0 | Partial | 2,915.12 | high_burden |
RT-KEN-2023-00011 | Kenya | 2,023 | Private facility | Lymphoma | 51 | Curative | Palliative RT | 27 | 2.8 | 50.4 | IMRT | Linear accelerator | Yes | 33 | Yes | Yes | Daily | 2 | 2 | Complete | 3,426.55 | high_burden |
RT-TAN-2023-00012 | Tanzania | 2,023 | National hospital | Breast | 35 | Curative | SBRT | 22 | 2.8 | 48 | IMRT | Linear accelerator | Yes | 72 | Yes | Yes | null | 0 | 0 | Stable | 1,899.71 | high_burden |
RT-UGA-2021-00013 | Uganda | 2,021 | National hospital | Head & Neck | 36 | Curative | Brachytherapy | 27 | 1.9 | 69.7 | VMAT | Cobalt-60 | Yes | 9 | Yes | Yes | Weekly | 1 | 0 | Complete | 2,339.43 | high_burden |
RT-KEN-2024-00014 | Kenya | 2,024 | National hospital | Breast | 82 | Neoadjuvant | SBRT | 20 | 2.4 | 49.5 | 3D-CRT | Cobalt-60 | Yes | 73 | Yes | No | Weekly | 1 | 2 | Complete | 967.31 | high_burden |
RT-SOU-2020-00015 | South Africa | 2,020 | National hospital | Head & Neck | 64 | Curative | Palliative RT | 32 | 2.8 | 43.6 | 3D-CRT | Both available | No - abandoned | 8 | Yes | Yes | Daily | 2 | 0 | Complete | 2,312.09 | high_burden |
RT-NIG-2022-00016 | Nigeria | 2,022 | Private facility | Lung | 21 | Curative | Combined EBRT+Brachy | 13 | 2 | 21.6 | 3D-CRT | Cobalt-60 | Yes | 32 | No | Yes | Weekly | 0 | 0 | Stable | 4,361.01 | high_burden |
RT-UGA-2022-00017 | Uganda | 2,022 | Regional cancer center | Brain | 60 | Palliative | Palliative RT | 1 | 2.3 | 17.1 | 3D-CRT | Cobalt-60 | Yes | 77 | Yes | No | Daily | 1 | 1 | Complete | 1,663.44 | high_burden |
RT-TAN-2018-00018 | Tanzania | 2,018 | National hospital | Colorectal | 44 | Neoadjuvant | SBRT | 20 | 2.6 | 53.3 | IMRT | Linear accelerator | Yes | 28 | Yes | Yes | Weekly | 1 | 2 | Complete | 3,670.84 | high_burden |
RT-UGA-2025-00019 | Uganda | 2,025 | Private facility | Colorectal | 23 | Curative | Palliative RT | 26 | 2.8 | 69.1 | 3D-CRT | Cobalt-60 | Yes | 25 | Yes | Yes | null | 1 | 0 | Partial | 1,283.25 | high_burden |
RT-GHA-2021-00020 | Ghana | 2,021 | Private facility | Esophagus | 24 | Curative | SBRT | 20 | 2.8 | 62.1 | 3D-CRT | Both available | Yes | 66 | Yes | Yes | Weekly | 3 | 0 | Progressive | 4,505.26 | high_burden |
RT-UGA-2024-00021 | Uganda | 2,024 | National hospital | Colorectal | 45 | Adjuvant | Combined EBRT+Brachy | 18 | 2.3 | 67.6 | IMRT | Linear accelerator | Ongoing | 85 | Yes | Yes | Daily | 1 | 3 | Complete | 4,930.39 | high_burden |
RT-KEN-2020-00022 | Kenya | 2,020 | Private facility | Prostate | 29 | Palliative | Combined EBRT+Brachy | 6 | 1.9 | 25 | IMRT | Linear accelerator | Yes | 78 | Yes | Yes | Daily | 0 | 2 | Partial | 2,562.4 | high_burden |
RT-SOU-2024-00023 | South Africa | 2,024 | Regional cancer center | Head & Neck | 68 | Curative | Combined EBRT+Brachy | 37 | 2.4 | 52.1 | VMAT | Cobalt-60 | Yes | 46 | Yes | Yes | Daily | 2 | 0 | Partial | 1,392.24 | high_burden |
RT-GHA-2022-00024 | Ghana | 2,022 | National hospital | Brain | 43 | Adjuvant | SBRT | 3 | 3 | 58.8 | IMRT | Cobalt-60 | Yes | 36 | Yes | Yes | null | 1 | 1 | Partial | 4,588.75 | high_burden |
RT-NIG-2018-00025 | Nigeria | 2,018 | National hospital | Cervix | 47 | Curative | External beam RT | 36 | 2.2 | 47.3 | 2D | Both available | No - abandoned | 40 | Yes | Yes | Unknown | 3 | 0 | Complete | 4,596.32 | high_burden |
RT-KEN-2024-00026 | Kenya | 2,024 | Private facility | Cervix | 37 | Palliative | Brachytherapy | 4 | 1.9 | 13.7 | 3D-CRT | Not specified | Yes | 65 | No | No | Unknown | 4 | 1 | Complete | 1,780.76 | high_burden |
RT-UGA-2021-00027 | Uganda | 2,021 | Private facility | Lung | 23 | Curative | SBRT | 3 | 2 | 19.2 | 2D | Both available | Yes | 32 | No | Yes | null | 4 | 0 | Partial | 2,579.08 | high_burden |
RT-KEN-2025-00028 | Kenya | 2,025 | National hospital | Colorectal | 24 | Curative | Combined EBRT+Brachy | 30 | 2.7 | 56.4 | 3D-CRT | Linear accelerator | Yes | 27 | Yes | No | null | 1 | 0 | Partial | 4,077.1 | high_burden |
RT-NIG-2025-00029 | Nigeria | 2,025 | Regional cancer center | Cervix | 69 | Curative | External beam RT | 18 | 2.2 | 53.7 | IMRT | Cobalt-60 | Yes | 52 | Yes | Yes | Unknown | 3 | 0 | Complete | 1,593.96 | high_burden |
RT-TAN-2022-00030 | Tanzania | 2,022 | National hospital | Prostate | 84 | Curative | SBRT | 32 | 2.2 | 46.4 | 3D-CRT | Cobalt-60 | Yes | 62 | No | Yes | Weekly | 2 | 2 | Progressive | 2,360.36 | high_burden |
RT-KEN-2019-00031 | Kenya | 2,019 | National hospital | Breast | 31 | Curative | Palliative RT | 22 | 2.4 | 52.6 | IMRT | Cobalt-60 | No - abandoned | 33 | Yes | Yes | Daily | 2 | 0 | Complete | 1,457.6 | high_burden |
RT-ETH-2024-00032 | Ethiopia | 2,024 | Private facility | Prostate | 77 | Palliative | External beam RT | 3 | 2.7 | 21.4 | VMAT | Linear accelerator | No - abandoned | 15 | Yes | Yes | Daily | 1 | 0 | Complete | 4,433.39 | high_burden |
RT-ETH-2020-00033 | Ethiopia | 2,020 | Private facility | Head & Neck | 71 | Curative | Palliative RT | 27 | 2 | 42.7 | 3D-CRT | Linear accelerator | Yes | 26 | Yes | Yes | null | 0 | 0 | Stable | 2,059.74 | high_burden |
RT-SOU-2023-00034 | South Africa | 2,023 | National hospital | Head & Neck | 33 | Palliative | SBRT | 2 | 2.3 | 19.1 | 3D-CRT | Both available | No - abandoned | 20 | Yes | No | Daily | 0 | 0 | Stable | 2,696.52 | high_burden |
RT-SOU-2021-00035 | South Africa | 2,021 | Regional cancer center | Lymphoma | 72 | Curative | Palliative RT | 24 | 2.7 | 46.1 | 3D-CRT | Not specified | No - toxicity | 71 | Yes | Yes | null | 3 | 1 | Complete | 1,283.06 | high_burden |
RT-SOU-2023-00036 | South Africa | 2,023 | Regional cancer center | Breast | 21 | Curative | Brachytherapy | 32 | 2 | 55.2 | IMRT | Cobalt-60 | Yes | 48 | Yes | Yes | null | 1 | 0 | Partial | 4,752.9 | high_burden |
RT-UGA-2021-00037 | Uganda | 2,021 | Regional cancer center | Prostate | 26 | Palliative | SBRT | 8 | 2.2 | 23.5 | 3D-CRT | Not specified | Yes | 89 | Yes | No | Daily | 2 | 0 | Complete | 2,210.56 | high_burden |
RT-KEN-2025-00038 | Kenya | 2,025 | Private facility | Colorectal | 29 | Adjuvant | Brachytherapy | 20 | 2.9 | 61.7 | 3D-CRT | Cobalt-60 | Yes | 35 | Yes | Yes | Weekly | 0 | 0 | Complete | 4,946.87 | high_burden |
RT-KEN-2025-00039 | Kenya | 2,025 | Private facility | Cervix | 42 | Curative | Combined EBRT+Brachy | 20 | 2.1 | 51.8 | 3D-CRT | Linear accelerator | Yes | 24 | No | Yes | null | 3 | 2 | Complete | 1,952.54 | high_burden |
RT-TAN-2022-00040 | Tanzania | 2,022 | Private facility | Head & Neck | 70 | Curative | Combined EBRT+Brachy | 34 | 2.5 | 68.7 | VMAT | Cobalt-60 | No - abandoned | 86 | Yes | No | Weekly | 2 | 0 | Stable | 2,931.42 | high_burden |
RT-UGA-2018-00041 | Uganda | 2,018 | National hospital | Colorectal | 35 | Adjuvant | External beam RT | 28 | 2.4 | 66.9 | VMAT | Cobalt-60 | Yes | 68 | Yes | Yes | Daily | 1 | 1 | Complete | 1,885.94 | high_burden |
RT-UGA-2023-00042 | Uganda | 2,023 | Private facility | Esophagus | 25 | Curative | Combined EBRT+Brachy | 20 | 2.3 | 56.7 | 3D-CRT | Cobalt-60 | No - toxicity | 46 | Yes | Yes | Daily | 2 | 0 | Complete | 3,234.73 | high_burden |
RT-NIG-2025-00043 | Nigeria | 2,025 | National hospital | Lung | 63 | Palliative | SBRT | 2 | 1.9 | 14.4 | Not specified | Both available | No - toxicity | 22 | No | Yes | Daily | 2 | 1 | Complete | 2,918.18 | high_burden |
RT-GHA-2021-00044 | Ghana | 2,021 | Private facility | Esophagus | 45 | Curative | External beam RT | 35 | 1.9 | 63.1 | IMRT | Linear accelerator | Yes | 87 | Yes | Yes | Daily | 1 | 3 | Stable | 2,687.1 | high_burden |
RT-GHA-2025-00045 | Ghana | 2,025 | National hospital | Lymphoma | 61 | Adjuvant | External beam RT | 21 | 2.1 | 44 | 3D-CRT | Both available | No - abandoned | 41 | Yes | Yes | Weekly | 1 | 0 | Complete | 1,316.32 | high_burden |
RT-KEN-2018-00046 | Kenya | 2,018 | National hospital | Prostate | 63 | Curative | SBRT | 16 | 2.8 | 57.1 | 3D-CRT | Not specified | Yes | 56 | Yes | Yes | Daily | 2 | 1 | Partial | 4,800.57 | high_burden |
RT-GHA-2025-00047 | Ghana | 2,025 | Private facility | Colorectal | 35 | Curative | External beam RT | 27 | 2.8 | 53.6 | IMRT | Linear accelerator | Yes | 64 | Yes | Yes | Weekly | 3 | 0 | Complete | 3,799.89 | high_burden |
RT-UGA-2020-00048 | Uganda | 2,020 | Private facility | Brain | 74 | Palliative | External beam RT | 6 | 1.9 | 12 | VMAT | Cobalt-60 | Yes | 18 | Yes | Yes | Weekly | 1 | 2 | Partial | 1,499.24 | high_burden |
RT-UGA-2021-00049 | Uganda | 2,021 | Regional cancer center | Head & Neck | 45 | Neoadjuvant | External beam RT | 32 | 2.8 | 63.9 | 3D-CRT | Linear accelerator | Yes | 24 | Yes | Yes | Weekly | 1 | 0 | Complete | 4,610.56 | high_burden |
RT-GHA-2023-00050 | Ghana | 2,023 | Regional cancer center | Lung | 20 | Curative | Brachytherapy | 4 | 2.4 | 46.6 | IMRT | Both available | Yes | 86 | Yes | Yes | null | 1 | 0 | Partial | 3,936.24 | high_burden |
RT-GHA-2018-00051 | Ghana | 2,018 | Private facility | Colorectal | 40 | Curative | SBRT | 17 | 1.8 | 64.6 | 2D | Linear accelerator | Yes | 21 | Yes | Yes | Weekly | 1 | 0 | Partial | 861.96 | high_burden |
RT-KEN-2023-00052 | Kenya | 2,023 | National hospital | Esophagus | 43 | Curative | Brachytherapy | 32 | 2.7 | 65.4 | 3D-CRT | Cobalt-60 | Yes | 8 | Yes | Yes | null | 2 | 1 | Complete | 4,427.53 | high_burden |
RT-UGA-2024-00053 | Uganda | 2,024 | National hospital | Lymphoma | 20 | Adjuvant | Palliative RT | 19 | 2.2 | 48.9 | VMAT | Cobalt-60 | Yes | 39 | Yes | Yes | Daily | 2 | 3 | Partial | 3,590.63 | high_burden |
RT-SOU-2019-00054 | South Africa | 2,019 | Private facility | Lymphoma | 46 | Curative | Brachytherapy | 37 | 2.5 | 55.1 | 3D-CRT | Cobalt-60 | Yes | 66 | Yes | Yes | Unknown | 2 | 0 | Progressive | 3,073.7 | high_burden |
RT-KEN-2020-00055 | Kenya | 2,020 | Regional cancer center | Head & Neck | 57 | Palliative | External beam RT | 5 | 2.2 | 20.5 | 3D-CRT | Linear accelerator | Yes | 50 | Yes | Yes | Weekly | 0 | 0 | Stable | 1,932.42 | high_burden |
RT-UGA-2025-00056 | Uganda | 2,025 | National hospital | Head & Neck | 62 | Curative | Brachytherapy | 22 | 2.2 | 49 | VMAT | Linear accelerator | No - abandoned | 74 | Yes | Yes | Unknown | 1 | 0 | Complete | 1,602.82 | high_burden |
RT-ETH-2018-00057 | Ethiopia | 2,018 | National hospital | Lung | 79 | Neoadjuvant | SBRT | 9 | 2.8 | 56.7 | 2D | Linear accelerator | Yes | 13 | Yes | No | Unknown | 2 | 0 | Partial | 1,916.59 | high_burden |
RT-TAN-2019-00058 | Tanzania | 2,019 | National hospital | Head & Neck | 81 | Adjuvant | Combined EBRT+Brachy | 29 | 2.1 | 63.6 | IMRT | Linear accelerator | Yes | 45 | Yes | No | Weekly | 3 | 3 | Partial | 1,069.82 | high_burden |
RT-GHA-2022-00059 | Ghana | 2,022 | National hospital | Head & Neck | 28 | Palliative | Brachytherapy | 7 | 2.2 | 19.9 | IMRT | Both available | Yes | 89 | Yes | No | Unknown | 1 | 1 | Stable | 1,233.11 | high_burden |
RT-NIG-2023-00060 | Nigeria | 2,023 | Regional cancer center | Lymphoma | 78 | Neoadjuvant | Combined EBRT+Brachy | 31 | 2.9 | 49.6 | 3D-CRT | Cobalt-60 | No - abandoned | 26 | Yes | Yes | Weekly | 1 | 0 | Partial | 2,677.88 | high_burden |
RT-KEN-2020-00061 | Kenya | 2,020 | Regional cancer center | Cervix | 47 | Curative | Palliative RT | 21 | 2.4 | 51.4 | IMRT | Cobalt-60 | Yes | 31 | Yes | Yes | Weekly | 0 | 0 | Stable | 3,977.49 | high_burden |
RT-UGA-2019-00062 | Uganda | 2,019 | National hospital | Colorectal | 23 | Curative | Palliative RT | 20 | 2.9 | 61.7 | IMRT | Cobalt-60 | Yes | 32 | Yes | Yes | Weekly | 1 | 1 | Partial | 4,971.25 | high_burden |
RT-GHA-2022-00063 | Ghana | 2,022 | Private facility | Breast | 45 | Palliative | Palliative RT | 6 | 2.9 | 24.8 | IMRT | Not specified | No - abandoned | 43 | Yes | Yes | null | 3 | 0 | Progressive | 4,605.53 | high_burden |
RT-UGA-2020-00064 | Uganda | 2,020 | National hospital | Lung | 76 | Palliative | Palliative RT | 6 | 1.8 | 17.2 | 3D-CRT | Cobalt-60 | Yes | 56 | Yes | Yes | Weekly | 2 | 2 | Partial | 4,362.2 | high_burden |
RT-ETH-2023-00065 | Ethiopia | 2,023 | Private facility | Breast | 37 | Palliative | Combined EBRT+Brachy | 5 | 3 | 21.6 | VMAT | Cobalt-60 | Ongoing | 81 | Yes | Yes | Unknown | 2 | 2 | Complete | 2,739.49 | high_burden |
RT-TAN-2019-00066 | Tanzania | 2,019 | National hospital | Lymphoma | 42 | Adjuvant | External beam RT | 24 | 2.8 | 59.7 | IMRT | Linear accelerator | Ongoing | 32 | Yes | Yes | Daily | 2 | 1 | Partial | 3,758.58 | high_burden |
RT-TAN-2025-00067 | Tanzania | 2,025 | Private facility | Breast | 40 | Curative | Combined EBRT+Brachy | 27 | 2.5 | 58.4 | VMAT | Linear accelerator | No - abandoned | 50 | Yes | Yes | Weekly | 0 | 0 | Complete | 2,181.23 | high_burden |
RT-KEN-2023-00068 | Kenya | 2,023 | Regional cancer center | Colorectal | 32 | Palliative | Palliative RT | 6 | 2.2 | 25.1 | IMRT | Linear accelerator | Yes | 59 | Yes | Yes | null | 2 | 0 | Partial | 1,122.38 | high_burden |
RT-KEN-2018-00069 | Kenya | 2,018 | Private facility | Cervix | 40 | Adjuvant | SBRT | 17 | 2.7 | 48.6 | Not specified | Linear accelerator | Yes | 16 | Yes | No | Daily | 1 | 2 | Progressive | 2,308.41 | high_burden |
RT-ETH-2022-00070 | Ethiopia | 2,022 | Regional cancer center | Esophagus | 72 | Curative | Combined EBRT+Brachy | 16 | 2.1 | 67.7 | 3D-CRT | Linear accelerator | No - toxicity | 43 | Yes | No | Weekly | 3 | 2 | Stable | 3,843.12 | high_burden |
RT-KEN-2019-00071 | Kenya | 2,019 | Regional cancer center | Brain | 82 | Adjuvant | Combined EBRT+Brachy | 5 | 2.1 | 18.1 | VMAT | Linear accelerator | No - abandoned | 40 | No | No | null | 0 | 0 | Partial | 1,018.26 | high_burden |
RT-ETH-2020-00072 | Ethiopia | 2,020 | Private facility | Brain | 83 | Adjuvant | Combined EBRT+Brachy | 10 | 1.8 | 45.6 | IMRT | Cobalt-60 | Yes | 88 | No | No | Daily | 2 | 0 | Progressive | 1,562.97 | high_burden |
RT-UGA-2025-00073 | Uganda | 2,025 | National hospital | Brain | 25 | Neoadjuvant | SBRT | 9 | 2.6 | 43.5 | VMAT | Cobalt-60 | Yes | 27 | Yes | Yes | Daily | 1 | 1 | Stable | 2,098.45 | high_burden |
RT-UGA-2018-00074 | Uganda | 2,018 | Private facility | Lymphoma | 32 | Curative | Palliative RT | 17 | 2 | 68.7 | IMRT | Not specified | No - toxicity | 64 | No | Yes | Unknown | 3 | 1 | Partial | 4,120.84 | high_burden |
RT-UGA-2018-00075 | Uganda | 2,018 | National hospital | Brain | 71 | Adjuvant | Palliative RT | 3 | 1.9 | 68.2 | IMRT | Linear accelerator | No - abandoned | 20 | Yes | Yes | Daily | 3 | 0 | Stable | 4,327.82 | high_burden |
RT-TAN-2023-00076 | Tanzania | 2,023 | Private facility | Lymphoma | 54 | Neoadjuvant | Brachytherapy | 24 | 2.6 | 65.6 | 3D-CRT | Linear accelerator | Yes | 59 | No | Yes | Weekly | 0 | 1 | Progressive | 3,527.24 | high_burden |
RT-KEN-2020-00077 | Kenya | 2,020 | National hospital | Head & Neck | 70 | Palliative | Brachytherapy | 5 | 2.7 | 26.6 | 2D | Cobalt-60 | Yes | 32 | Yes | Yes | Unknown | 4 | 0 | Partial | 1,057.95 | high_burden |
RT-UGA-2018-00078 | Uganda | 2,018 | Regional cancer center | Lymphoma | 28 | Curative | Palliative RT | 24 | 2.4 | 56.8 | IMRT | Cobalt-60 | Yes | 30 | Yes | Yes | Weekly | 1 | 2 | Partial | 1,280.09 | high_burden |
RT-UGA-2018-00079 | Uganda | 2,018 | Regional cancer center | Lymphoma | 56 | Curative | External beam RT | 34 | 2.7 | 55.9 | IMRT | Linear accelerator | Yes | 43 | Yes | No | Weekly | 2 | 2 | Progressive | 2,523.43 | high_burden |
RT-ETH-2022-00080 | Ethiopia | 2,022 | National hospital | Prostate | 84 | Curative | SBRT | 33 | 1.9 | 51.8 | 3D-CRT | Linear accelerator | Ongoing | 67 | No | No | Weekly | 1 | 2 | Stable | 2,698.66 | high_burden |
RT-NIG-2020-00081 | Nigeria | 2,020 | Private facility | Brain | 24 | Palliative | Palliative RT | 9 | 2.9 | 16.5 | VMAT | Not specified | Yes | 50 | Yes | No | Weekly | 0 | 0 | Partial | 4,882.33 | high_burden |
RT-NIG-2019-00082 | Nigeria | 2,019 | National hospital | Prostate | 63 | Neoadjuvant | SBRT | 17 | 1.9 | 46.8 | 3D-CRT | Linear accelerator | Yes | 8 | Yes | Yes | Weekly | 3 | 1 | Partial | 4,172.22 | high_burden |
RT-NIG-2024-00083 | Nigeria | 2,024 | National hospital | Breast | 59 | Curative | SBRT | 25 | 2 | 70 | Not specified | Both available | No - toxicity | 81 | Yes | Yes | null | 1 | 0 | Complete | 3,053 | high_burden |
RT-TAN-2020-00084 | Tanzania | 2,020 | Private facility | Head & Neck | 58 | Neoadjuvant | Palliative RT | 33 | 2.8 | 56.1 | IMRT | Linear accelerator | No - abandoned | 57 | Yes | Yes | Daily | 3 | 0 | Complete | 4,161.58 | high_burden |
RT-TAN-2025-00085 | Tanzania | 2,025 | Private facility | Breast | 51 | Adjuvant | Combined EBRT+Brachy | 24 | 2 | 44.6 | 3D-CRT | Linear accelerator | No - toxicity | 62 | Yes | Yes | Daily | 2 | 1 | Stable | 3,261.32 | high_burden |
RT-TAN-2023-00086 | Tanzania | 2,023 | National hospital | Head & Neck | 37 | Curative | Combined EBRT+Brachy | 18 | 2.1 | 40.7 | IMRT | Both available | No - abandoned | 37 | No | Yes | Unknown | 2 | 1 | Progressive | 4,081.75 | high_burden |
RT-TAN-2021-00087 | Tanzania | 2,021 | Private facility | Lung | 68 | Palliative | SBRT | 2 | 2.4 | 14.7 | IMRT | Linear accelerator | No - abandoned | 54 | Yes | Yes | Weekly | 4 | 0 | Progressive | 2,986.3 | high_burden |
RT-TAN-2023-00088 | Tanzania | 2,023 | Regional cancer center | Esophagus | 39 | Adjuvant | Palliative RT | 39 | 2.6 | 54 | 3D-CRT | Linear accelerator | No - toxicity | 31 | Yes | Yes | Daily | 2 | 1 | Progressive | 3,026.84 | high_burden |
RT-TAN-2019-00089 | Tanzania | 2,019 | Private facility | Cervix | 61 | Adjuvant | SBRT | 15 | 1.8 | 40.3 | 3D-CRT | Linear accelerator | Ongoing | 81 | No | Yes | null | 3 | 2 | Complete | 963.39 | high_burden |
RT-KEN-2018-00090 | Kenya | 2,018 | National hospital | Lung | 72 | Palliative | External beam RT | 3 | 2.4 | 19.2 | 3D-CRT | Linear accelerator | No - abandoned | 57 | Yes | Yes | null | 1 | 2 | Complete | 3,878.99 | high_burden |
RT-GHA-2022-00091 | Ghana | 2,022 | Regional cancer center | Lymphoma | 51 | Neoadjuvant | Combined EBRT+Brachy | 23 | 2.6 | 64.9 | 3D-CRT | Cobalt-60 | Yes | 45 | Yes | Yes | Weekly | 0 | 0 | Partial | 2,124.89 | high_burden |
RT-TAN-2022-00092 | Tanzania | 2,022 | National hospital | Brain | 69 | Curative | External beam RT | 10 | 2.8 | 35.1 | IMRT | Cobalt-60 | Yes | 15 | Yes | No | Daily | 1 | 1 | Complete | 1,309.48 | high_burden |
RT-KEN-2020-00093 | Kenya | 2,020 | Private facility | Colorectal | 24 | Palliative | Palliative RT | 4 | 2.4 | 20.2 | VMAT | Cobalt-60 | Yes | 76 | Yes | Yes | null | 3 | 0 | Stable | 3,947.55 | high_burden |
RT-TAN-2022-00094 | Tanzania | 2,022 | Private facility | Lymphoma | 29 | Neoadjuvant | Combined EBRT+Brachy | 16 | 2.6 | 68.4 | 2D | Both available | Yes | 24 | Yes | No | Weekly | 0 | 0 | Progressive | 889.2 | high_burden |
RT-ETH-2019-00095 | Ethiopia | 2,019 | Private facility | Head & Neck | 49 | Adjuvant | SBRT | 27 | 2.8 | 57.5 | IMRT | Not specified | Yes | 14 | No | Yes | null | 4 | 0 | Complete | 1,263.21 | high_burden |
RT-TAN-2019-00096 | Tanzania | 2,019 | National hospital | Lymphoma | 30 | Curative | External beam RT | 20 | 2.8 | 61.5 | VMAT | Both available | Yes | 10 | No | Yes | null | 1 | 1 | Stable | 832.38 | high_burden |
RT-UGA-2022-00097 | Uganda | 2,022 | Regional cancer center | Prostate | 20 | Adjuvant | Combined EBRT+Brachy | 24 | 2.7 | 56.9 | Not specified | Cobalt-60 | Ongoing | 35 | Yes | Yes | Weekly | 2 | 0 | Partial | 4,866.55 | high_burden |
RT-NIG-2019-00098 | Nigeria | 2,019 | Private facility | Lung | 48 | Curative | SBRT | 11 | 2.9 | 61.3 | 2D | Both available | Yes | 63 | Yes | Yes | Weekly | 1 | 0 | Progressive | 3,066.79 | high_burden |
RT-TAN-2023-00099 | Tanzania | 2,023 | Regional cancer center | Cervix | 57 | Adjuvant | SBRT | 18 | 2.6 | 47.1 | IMRT | Cobalt-60 | Yes | 16 | No | Yes | Unknown | 2 | 2 | Partial | 3,937.44 | high_burden |
RT-UGA-2020-00100 | Uganda | 2,020 | Private facility | Colorectal | 33 | Curative | External beam RT | 24 | 3 | 67.2 | VMAT | Cobalt-60 | Yes | 68 | Yes | Yes | null | 2 | 1 | Partial | 3,500.54 | high_burden |
Cancer Radiotherapy Treatment Africa | Africa (Electric Sheep Africa metadata inventory)
Size category: 10K<n<100K - Formats: csv - Sector: health - Engineered by Electric Sheep Africa
TL;DR
This dataset is part of the Electric Sheep Africa catalog on Hugging Face. It is indexed for African data discovery with standardized metadata, loading guidance, provenance notes, and analyst-oriented context.
What This Dataset Covers
Health datasets help researchers examine disease burden, service delivery, risk factors, outcomes, and public-health program performance.
Dataset context from the existing Hugging Face card: ⚠️ Synthetic dataset — Parameterized from published SSA literature, not real observations. Not suitable for empirical analysis or policy inference. Cancer Radiotherapy Treatment Africa Abstract This synthetic dataset represents cancer radiotherapy treatment data across sub-Saharan Africa, capturing treatment parameters, equipment types, and outcomes. The dataset contains 2,800-4,200 records per scenario reflecting the limited radiotherapy infrastructure in the region.… See the full description on the dataset page: https://huggingface.co/datasets/electricsheepafrica/africa-synth-cancer-cancer-radiotherapy-treatment-all.
Dataset Profile
| Field | Value |
|---|---|
| Hugging Face repo | electricsheepafrica/africa-synth-cancer-cancer-radiotherapy-treatment-all |
| Sector | health |
| Topic tags | cancer, oncology, synthetic, healthcare, sub-saharan-africa, radiotherapy, radiation-oncology |
| Modalities | tabular, text |
| Formats | csv |
| Size category | 10K<n<100K |
| Countries | Africa-wide or source-defined African coverage |
| ISO3 coverage | not declared |
| Last modified on HF | 2026-04-14 22:50:01+00:00 |
| Inventory snapshot | 2026-07-16T16:00:34Z |
How To Read This Dataset
- Start from the repository files and the dataset viewer when available.
- Treat the README context as a fast orientation layer; confirm variable definitions and units in the data files before modeling.
- Use explicit country columns when present. When geography is only implied by the title or source metadata, document that assumption in downstream analysis.
- Preserve missing values until you have a defensible imputation rule.
Usage
from datasets import load_dataset
ds = load_dataset("electricsheepafrica/africa-synth-cancer-cancer-radiotherapy-treatment-all")
print(ds)
split_name = next(iter(ds))
table = ds[split_name]
print(table.features)
print(table[:3])
Convert To Pandas When Tabular
from datasets import Dataset
first_split = ds[next(iter(ds))]
if isinstance(first_split, Dataset):
df = first_split.to_pandas()
print(df.head())
Data Quality Notes
- This card was standardized from the Electric Sheep Africa Hugging Face metadata inventory.
- Exact schema, row counts, and source files should be inspected in the repository data files.
- Metadata gaps from the inventory: country, upstream_publisher.
- Do not infer policy meaning from labels alone; confirm definitions, units, and methods in the source material.
Source And Provenance
- Source context: Electric Sheep Africa metadata inventory
- Publisher/source attribution: Public dataset metadata
- License: CC BY 4.0
- Hugging Face URL: https://huggingface.co/datasets/electricsheepafrica/africa-synth-cancer-cancer-radiotherapy-treatment-all
- Inventory retrieved at:
2026-07-16T16:00:34Z
Suggested Analyses
- Inspect schema and missingness before modeling.
- Profile variables by geography, time, and subgroup columns where present.
- Join with other Electric Sheep Africa datasets using explicit country, year, and indicator fields when available.
- Build reproducible notebooks that cite both the original source context and the Electric Sheep Africa Hugging Face repo.
Citation
@misc{electric_sheep_africa_africa_synth_cancer_cancer_radiotherapy_treatment_all_2026,
title = {Cancer Radiotherapy Treatment Africa | Africa (Electric Sheep Africa metadata inventory)},
author = {Public dataset metadata},
year = {2026},
url = {https://huggingface.co/datasets/electricsheepafrica/africa-synth-cancer-cancer-radiotherapy-treatment-all},
publisher = {Hugging Face Datasets, engineered by Electric Sheep Africa},
howpublished = {\url{https://huggingface.co/datasets/electricsheepafrica/africa-synth-cancer-cancer-radiotherapy-treatment-all}}
}
License
Released under CC BY 4.0.
Original source rights remain with the original publisher or data provider. Electric Sheep Africa engineering standardizes discovery metadata, documentation, and usage guidance for analysis on Hugging Face.
About Electric Sheep Africa
Electric Sheep Africa publishes ML-ready African public datasets on Hugging Face.
Provenance: metadata-backed README standardized 2026-08-12 by the Electric Sheep Africa README system. Inventory source: catalog/esa_metadata_inventory/master_metadata.jsonl.
- Downloads last month
- 23